About MetLife (NYSE:MET)
MetLife, Inc. is a provider of life insurance, annuities, employee benefits and asset management. The Company's segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses. Its Asia segment offers products, including life insurance; accident and health insurance, and retirement and savings products. Latin America offers products, including life insurance, and retirement and savings products. Life insurance includes universal, variable and term life products. EMEA offers products, including life insurance, accident and health insurance, retirement and savings products, and credit insurance.
Industry, Sector and Symbol:
- Sector: Finance
- Industry: Life & Health Insurance
- Sub-Industry: Life & Health Insurance
- Symbol: NYSE:MET
- CUSIP: 59156R10
- Web: www.metlife.com
- Market Cap: $56.2252 billion
- Outstanding Shares: 1,062,868,000
- 50 Day Moving Avg: $50.77
- 200 Day Moving Avg: $48.11
- 52 Week Range: $40.30 - $53.58
Sales & Book Value:
- Trailing P/E Ratio: 626.94
- Foreward P/E Ratio: 11.27
- P/E Growth: 1.23
- Annual Revenue: $63.21 billion
- Price / Sales: 0.90
- Book Value: $65.31 per share
- Price / Book: 0.82
- Annual Dividend: $1.60
- Dividend Yield: 3.0%
- EBITDA: $817.5 million
- Net Margins: 0.30%
- Return on Equity: 8.51%
- Return on Assets: 0.65%
- Debt-to-Equity Ratio: 0.30%
- Current Ratio: 0.16%
- Quick Ratio: 0.16%
- Average Volume: 5.26 million shs.
- Beta: 1.47
- Short Ratio: 2.16
Frequently Asked Questions for MetLife (NYSE:MET)
What is MetLife's stock symbol?
MetLife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."
How often does MetLife pay dividends? What is the dividend yield for MetLife?
MetLife declared a quarterly dividend on Friday, July 7th. Investors of record on Monday, August 7th will be given a dividend of $0.40 per share on Wednesday, September 13th. This represents a $1.60 annualized dividend and a yield of 3.00%. The ex-dividend date of this dividend is Thursday, August 3rd. View MetLife's Dividend History.
How were MetLife's earnings last quarter?
MetLife, Inc. (NYSE:MET) announced its quarterly earnings data on Wednesday, August, 2nd. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.02. The business earned $17.39 billion during the quarter, compared to analysts' expectations of $17.11 billion. MetLife had a net margin of 0.30% and a return on equity of 8.51%. The company's revenue was up 2.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.83 earnings per share. View MetLife's Earnings History.
When will MetLife make its next earnings announcement?
Where is MetLife's stock going? Where will MetLife's stock price be in 2017?
15 equities research analysts have issued 1-year price objectives for MetLife's shares. Their predictions range from $51.00 to $78.00. On average, they anticipate MetLife's share price to reach $58.45 in the next year. View Analyst Ratings for MetLife.
What are analysts saying about MetLife stock?
Here are some recent quotes from research analysts about MetLife stock:
- 1. According to Zacks Investment Research, "Shares of MetLife have underperformed the industry year to date. Persistent decline in MetLife’s revenues, due to decline in premiums, low investment income, decline in fees collected from Universal LIfe and investment type product and lower other revenues for more than two years bothers us. Charges related to the BrightHouse Financial spinoff will drain the company’s earnings in the coming quarters. Also uncertainty relating to the company's stock has witnessed a downward revision in the Zacks Consensus Estimate for 2017 earnings in the past seven days." (10/9/2017)
- 2. Wells Fargo & Company analysts commented, "We sensed expectations among investors were low for MET going into Q1 earnings, and in our view the quarter at least met those expectations, with the majority of the outperformance relative to our expectation occurring in MetLife Holdings and the Corporate segment. We knew there was some re-positioning of hedging strategies going on in the quarter to make the derivative portfolio more “statutory-friendly” so we are not overly concerned with the net derivative losses (assuming they did not lower statutory capital levels, which will be discussed on the conference call on May 4). As we move toward the spin of Brighthouse, we can see the evolution of RemainCo MetLife’s less volatile earnings profile, which we believe will be rewarded with higher multiples over time." (5/4/2017)
Who are some of MetLife's key competitors?
Some companies that are related to MetLife include Prudential Public Limited Company (PUK), Prudential plc (PRU), Prudential Financial (PRU), Manulife Financial Corp (MFC), Aflac Incorporated (AFL), Sun Life Financial (SLF), Aviva plc (AV), Principal Financial Group (PFG), Lincoln National Corporation (LNC), Aegon NV (AEG), Unum Group (UNM), Athene Holding (ATH), Voya Financial (VOYA), StanCorp Financial Group (SFG), CNO Financial Group (CNO), Symetra Financial (SYA), Phoenix Group Holdings (PHNX) and Just Group PLC (JUST).
Who are MetLife's key executives?
MetLife's management team includes the folowing people:
- Steven A. Kandarian J.D., Chairman of the Board, President, Chief Executive Officer
- John C. R. Hele, Chief Financial Officer, Executive Vice President
- Michel Khalaf, President, EMEA
- Christopher G. Townsend, President, Asia
- Susan Podlogar, Chief Human Resource Officer, Executive Vice President
- William O'Donnell, Executive Vice President, Chief Accounting Officer
- Steven J. Goulart, Executive Vice President, Chief Investment Officer
- Esther Lee, Executive Vice President, Global Chief Marketing Officer
- Ricardo A. Anzaldua J.D., Executive Vice President, General Counsel
- Martin J. Lippert, Executive Vice President, Head - Global Technology and Operations
Who owns MetLife stock?
MetLife's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include
BOARD OF DIRECTORS OF METLIFE INC
(14.90%), Diamond Hill Capital Management Inc. (0.65%), Douglas Lane & Associates LLC (0.13%), Robeco Institutional Asset Management B.V. (0.06%), PGGM Investments (0.05%) and State Treasurer State of Michigan (0.03%). Company insiders that own MetLife stock include Frans Hijkoop, James M Kilts, Kenton J Sicchitano, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for MetLife.
Who sold MetLife stock? Who is selling MetLife stock?
MetLife's stock was sold by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Diamond Hill Capital Management Inc., Shell Asset Management Co., Beacon Financial Group, Quantitative Systematic Strategies LLC, State Treasurer State of Michigan, Narwhal Capital Management and Douglas Lane & Associates LLC. Company insiders that have sold MetLife stock in the last year include Frans Hijkoop, Maria R Morris and Peter M Carlson. View Insider Buying and Selling for MetLife.
Who bought MetLife stock? Who is buying MetLife stock?
MetLife's stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Hermes Investment Management Ltd., Robeco Institutional Asset Management B.V., Rockefeller Financial Services Inc., PGGM Investments, Lincoln Capital Corp, OLD Second National Bank of Aurora and First United Bank Trust. View Insider Buying and Selling for MetLife.
How do I buy MetLife stock?
Shares of MetLife can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is MetLife's stock price today?
MarketBeat Community Rating for MetLife (NYSE MET)MarketBeat's community ratings are surveys of what our community members think about MetLife and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of MetLife stock can currently be purchased for approximately $53.29.
Consensus Ratings for MetLife (NYSE:MET) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Sell Rating, 6 Hold Ratings, 7 Buy Ratings, 1 Strong Buy Rating|
|Consensus Rating:||Buy (Score: 2.53)|
|Consensus Price Target: ||$58.45 (9.68% upside)|Consensus Price Target History for MetLife (NYSE:MET)
Analysts' Ratings History for MetLife (NYSE:MET)
(Data available from 10/21/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|10/18/2017||Wells Fargo & Company||Reiterated Rating||Buy||N/A|
|10/18/2017||Goldman Sachs Group Inc||Initiated Coverage||Conviction-Buy||$61.00||N/A|
|10/10/2017||FBR & Co||Downgrade||Buy -> Neutral||$53.00 -> $52.00||N/A|
|10/5/2017||Morgan Stanley||Boost Price Target||Equal Weight||$54.00 -> $55.00||N/A|
|9/6/2017||Royal Bank Of Canada||Reiterated Rating||Buy||$56.00||Medium|
|8/28/2017||Credit Suisse Group||Reiterated Rating||Neutral||$64.00 -> $53.00||Low|
|8/16/2017||Langen Mcalenn||Reiterated Rating||Buy||Medium|
|8/11/2017||Barclays PLC||Lower Price Target||Overweight||$67.00 -> $60.00||Low|
|8/9/2017||Argus||Lower Price Target||Buy||$60.00 -> $55.00||Low|
|8/3/2017||Keefe, Bruyette & Woods||Reiterated Rating||Buy||$59.00||High|
|7/24/2017||J P Morgan Chase & Co||Initiated Coverage||Hold||$78.00||Low|
|7/7/2017||Citigroup Inc.||Set Price Target||Sell||$51.00||Low|
|3/6/2017||Bank of America Corporation||Downgrade||Buy -> Neutral||$54.20 -> $54.83||N/A|
|2/5/2017||Deutsche Bank AG||Reiterated Rating||Buy||$65.00||N/A|
|12/9/2016||Standpoint Research||Downgrade||Buy -> Hold||N/A|
|7/6/2016||Evercore ISI||Initiated Coverage||Buy||$52.00||N/A|
|6/27/2016||Sandler O'Neill||Upgrade||Hold -> Buy||N/A|
|2/8/2016||Raymond James Financial, Inc.||Lower Price Target||Strong-Buy||$56.00 -> $55.00||N/A|
|2/4/2016||Macquarie||Lower Price Target||Outperform||$55.00 -> $53.00||N/A|
|1/14/2016||Janney Montgomery Scott||Initiated Coverage||Buy||N/A|
|11/6/2015||Piper Jaffray Companies||Reiterated Rating||Neutral||$58.00 -> $57.00||N/A|
Earnings History for MetLife (NYSE:MET)Earnings History by Quarter for MetLife (NYSE MET)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/2/2017||Q2 2017||$1.28||$1.30||$17.11 billion||$17.39 billion||View||Listen|
|5/3/2017||Q1 2017||$1.27||$1.46||$17.02 billion||$16.27 billion||View||Listen|
|2/1/2017||Q416||$1.34||$1.28||$17.34 billion||$12.08 billion||View||Listen|
|11/2/2016||Q316||$1.14||$1.28||$17.03 billion||$17.70 billion||View||Listen|
|8/3/2016||Q216||$1.35||$0.83||$17.35 billion||$17.00 billion||View||Listen|
|5/4/2016||Q116||$1.38||$1.20||$17.16 billion||$16.61 billion||View||Listen|
|2/3/2016||Q415||$1.36||$1.23||$17.61 billion||$17.11 billion||View||Listen|
|11/4/2015||Q315||$0.76||$0.62||$17.77 billion||$17.97 billion||View||Listen|
|7/29/2015||Q215||$1.47||$1.56||$17.69 billion||$17.40 billion||View||Listen|
|5/6/2015||Q115||$1.41||$1.44||$17.53 billion||$17.03 billion||View||Listen|
|2/11/2015||Q414||$1.37||$1.38||$18.18 billion||$18.25 billion||View||Listen|
|10/29/2014||Q314||$1.38||$1.60||$17.65 billion||$17.92 billion||View||Listen|
|7/30/2014||Q214||$1.41||$1.39||$17.54 billion||$17.80 billion||View||Listen|
|4/30/2014||Q114||$1.40||$1.37||$17.50 billion||$17.12 billion||View||Listen|
|2/13/2014||Q413||$1.30||$1.37||$17.43 billion||$18.38 billion||View||Listen|
|10/31/2013||Q313||$1.34||$1.34||$17.23 billion||$16.90 billion||View||Listen|
|7/31/2013||Q2 2013||$1.33||$1.44||$17.31 billion||$17.04 billion||View||Listen|
|5/1/2013||Q1 2013||$1.31||$1.48||$17.34 billion||$17.00 million||View||Listen|
|2/13/2013||Q4 2012||$1.18||$1.25||$17.25 billion||$18.36 billion||View||Listen|
Earnings Estimates for MetLife (NYSE:MET)
2017 EPS Consensus Estimate: $4.62
2018 EPS Consensus Estimate: $5.26
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Current Dividend Information for MetLife (NYSE:MET)
|Most Recent Dividend:||9/13/2017|
|Dividend Growth:||16.00% (3 Year Average)|
|Payout Ratio:||1,777.98% (Trailing 12 Months of Earnings) |
38.00% (Based on This Year's Estimates)
33.83% (Based on Next Year's Estimates)
|Track Record:||4 Years of Consecutive Dividend Growth|
Dividend History by Quarter for MetLife (NYSE MET)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for MetLife (NYSE:MET)
Insider Ownership Percentage: 0.32%Insider Trades by Quarter for MetLife (NYSE:MET)
Institutional Ownership Percentage: 74.22%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|3/22/2017||James M Kilts||Director||Buy||17,205||$51.13||$879,691.65|| |
|3/1/2017||James M Kilts||Director||Buy||2,795||$54.17||$151,405.15|| |
|12/23/2016||Peter M Carlson||EVP||Sell||23,636||$54.32||$1,283,907.52|| |
|12/1/2016||Frans Hijkoop||EVP||Sell||14,997||$56.18||$842,531.46|| |
|11/9/2016||Frans Hijkoop||EVP||Sell||56,250||$51.48||$2,895,750.00|| |
|11/1/2016||Maria R Morris||EVP||Sell||2,200||$47.33||$104,126.00|| |
|10/4/2016||Maria R Morris||EVP||Sell||8,800||$45.00||$396,000.00|| |
|8/2/2016||Maria R Morris||EVP||Sell||2,000||$42.96||$85,920.00|| |
|7/1/2016||Maria R Morris||EVP||Sell||2,000||$39.43||$78,860.00|| |
|6/1/2016||Maria R Morris||EVP||Sell||4,200||$45.15||$189,630.00|| |
|5/2/2016||Maria R Morris||EVP||Sell||4,200||$45.46||$190,932.00|| |
|4/18/2016||Maria R Morris||EVP||Sell||2,200||$45.00||$99,000.00|| |
|3/30/2016||Maria R Morris||EVP||Sell||4,400||$45.00||$198,000.00|| |
|3/1/2016||Maria R Morris||EVP||Sell||2,000||$39.97||$79,940.00|| |
|2/1/2016||Maria R. Morris||EVP||Sell||2,000||$44.31||$88,620.00|| |
|12/2/2015||Kenton J Sicchitano||Director||Sell||9,503||$50.78||$482,562.34|| |
|12/1/2015||Maria R. Morris||EVP||Sell||4,200||$51.23||$215,166.00|| |
|11/2/2015||Maria R. Morris||EVP||Sell||4,200||$50.60||$212,520.00|| |
|10/1/2015||Maria R. Morris||EVP||Sell||4,200||$47.22||$198,324.00|| |
|9/1/2015||Maria R. Morris||EVP||Sell||4,200||$48.42||$203,364.00|| |
|7/1/2015||Maria R Morris||EVP||Sell||6,200||$57.00||$353,400.00|| |
|6/22/2015||Steven A Kandarian||CEO||Sell||17,500||$57.12||$999,600.00|| |
|6/2/2015||Maria R Morris||EVP||Sell||6,200||$52.41||$324,942.00|| |
|5/1/2015||Maria R Morris||EVP||Sell||4,200||$51.72||$217,224.00|| |
|4/1/2015||Maria R Morris||EVP||Sell||4,200||$50.24||$211,008.00|| |
|3/6/2015||Maria R Morris||EVP||Sell||2,000||$53.00||$106,000.00|| |
|3/2/2015||Maria R Morris||EVP||Sell||4,200||$50.63||$212,646.00|| |
|2/2/2015||Maria R Morris||EVP||Sell||4,200||$46.85||$196,770.00|| |
|1/2/2015||Maria R Morris||EVP||Sell||4,200||$54.58||$229,236.00|| |
|10/28/2014||Maria R Morris||EVP||Sell||18,300||$51.74||$946,842.00|| |
|6/12/2014||Peter M Carlson||CAO||Sell||91,625||$54.29||$4,974,321.25|| |
|3/6/2014||Beth Hirschhorn||EVP||Sell||30,594||$52.44||$1,604,349.36|| |
|12/24/2013||Maria Morris||EVP||Sell||12,000||$53.08||$636,960.00|| |
|8/14/2013||John Keane||Director||Sell||1,210||$49.57||$59,979.70|| |
|8/5/2013||William Wheeler||Insider||Sell||40,000||$50.92||$2,036,800.00|| |
|5/29/2013||Beth Hirschhorn||EVP||Sell||20,764||$44.18||$917,353.52|| |
|5/8/2013||Kenton J Sicchitano||Director||Sell||1,536||$40.77||$62,622.72|| |
Headline Trends for MetLife (NYSE:MET)
Latest Headlines for MetLife (NYSE:MET)
Loading headlines, please wait.
MetLife (MET) Chart for Saturday, October, 21, 2017